A novel dried blood spot LC–MS/MS method for the quantification of apalutamide in mouse whole blood: Application to pharmacokinetic study in mice
Authors:
- 13 August 2018
- journal article
- research article
- Published by Wiley in Biomedical Chromatography
- Vol. 32 (11) , e4344
Abstract
A simple, sensitive and rapid assay method has been developed and validated for the estimation of apalutamide on mouse dried blood spots (DBS) using liquid chromatography coupled to tandem mass spectrometry with electrospray ionization in the positive‐ion mode. The method utilizes liquid extraction of apalutamide from 3 mm punched disks from DBS cards (spiked or study samples). The extracted sample was chromatographed on an Atlantis dC18 column using gradient elution with 0.2% formic acid and acetonitrile at a flow rate of 1.00 mL/min. The total run time was 3.0 min. The MS/MS ion transitions monitored were m/z 478 → 450 for apalutamide and m/z 481 → 453 for the IS (apalutamide‐d3). Method validation was performed as per regulatory guidelines. The assay was linear in the range of 0.95–2030 ng/mL. The intra‐ and inter‐day precisions were in the ranges of 2.37–8.53 and 6.76–11.5%, respectively. Stability studies showed that apalutamide was stable on DBS cards for one month. This novel method has been applied to analyze the DBS samples of apalutamide obtained from a pharmacokinetic study in mice.Keywords
This publication has 11 references indexed in Scilit:
- Validation of an LC-ESI–MS/MS method for the determination of apalutamide, a novel non-steroidal anti-androgen in mice plasma and its application to a pharmacokinetic study in miceJournal of Pharmaceutical and Biomedical Analysis, 2018
- State of the Science in Dried Blood SpotsClinical Chemistry, 2018
- Design, synthesis, and biological evaluation of deuterated apalutamide with improved pharmacokinetic profilesBioorganic & Medicinal Chemistry Letters, 2017
- Abiraterone acetatefor the treatment of prostate cancerExpert Opinion on Pharmacotherapy, 2012
- Dried Blood Spots: Analysis and ApplicationsAnalytical Chemistry, 2012
- Abiraterone acetate for treatment of metastatic castration-resistant prostate cancer: final overall survival analysis of the COU-AA-301 randomised, double-blind, placebo-controlled phase 3 studyThe Lancet Oncology, 2012
- Increased Survival with Enzalutamide in Prostate Cancer after ChemotherapyNew England Journal of Medicine, 2012
- ARN-509: A Novel Antiandrogen for Prostate Cancer TreatmentCancer Research, 2012
- Development of a Second-Generation Antiandrogen for Treatment of Advanced Prostate CancerScience, 2009
- The effects of sample preparation methods on the variability of the electrospray ionization response for model drug compoundsRapid Communications in Mass Spectrometry, 1999